AbbVie Joins US Drug Rebate Pilot

AbbVie will participate in a US government pilot starting next year to test a new rebate system for discounted medicines under the 340B program. The initiative aims to improve pricing transparency and prevent duplicate discounts for key drugs.

Xurve View
Insights:
FILE PHOTO: A sign stands outside a Abbvie facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File Photo

ABBVIE INC will join a United States government pilot program to test a new drug discount rebate system starting January 1, 2027. The initiative tests pricing models under the 340B program for low-income healthcare providers. The rollout helps prevent duplicate discounts as Medicare-negotiated drug prices take effect.